Empresa Edge Therapeutics Inc Nasdaq
Acciones
US2798701098
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 15/03/19 |
Director of Finance/CFO | 55 | 04/12 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/22 |
Spencer Brown
CMP | Compliance Officer | 54 | 01/06/22 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/05 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 02/04/19 |
Otis Brawley
BRD | Director/Board Member | 64 | 03/11/20 |
Richard Sykes
BRD | Director/Board Member | 79 | 01/03/19 |
Director/Board Member | 65 | 21/02/20 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 01/03/19 |
Frank Bedu-Addo
FOU | Founder | 59 | 15/03/19 |
Ilian Iliev
BRD | Director/Board Member | 48 | 08/04/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 36 679 275 | 35 209 588 ( 95,99 %) | 0 | 95,99 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,52 % | 111 mil M | |
+11,38 % | 106 mil M | |
-12,64 % | 22,24 mil M | |
+0,44 % | 21,25 mil M | |
-4,18 % | 18,97 mil M | |
-37,85 % | 18,52 mil M | |
-8,58 % | 16,81 mil M | |
+37,41 % | 12,54 mil M | |
-23,95 % | 8089,74 M |